BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9756620)

  • 1. Deletion analysis of protein kinase Calpha reveals a novel regulatory segment.
    Rotenberg SA; Zhu J; Hansen H; Li XD; Sun XG; Michels CA; Riedel H
    J Biochem; 1998 Oct; 124(4):756-63. PubMed ID: 9756620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells.
    Sullivan RM; Stone M; Marshall JF; Uberall F; Rotenberg SA
    Mol Pharmacol; 2000 Oct; 58(4):729-37. PubMed ID: 10999942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequence.
    Kirwan AF; Bibby AC; Mvilongo T; Riedel H; Burke T; Millis SZ; Parissenti AM
    Biochem J; 2003 Jul; 373(Pt 2):571-81. PubMed ID: 12710889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of regulation of phospholipase D1 by protein kinase Calpha.
    Hu T; Exton JH
    J Biol Chem; 2003 Jan; 278(4):2348-55. PubMed ID: 12431982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective loss of substrate recognition induced by the tumour-associated D294G point mutation in protein kinase Calpha.
    Prévostel C; Alvaro V; Vallentin A; Martin A; Jaken S; Joubert D
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):393-7. PubMed ID: 9716497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional carboxyl terminal deletion map of protein kinase C alpha.
    Su L; Parissenti AM; Riedel H
    Recept Channels; 1993; 1(1):1-9. PubMed ID: 8081709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional binding sites for anionic phospholipids and calcium ions in the crystal structures of complexes of the C2 domain of protein kinase calpha.
    Ochoa WF; Corbalán-Garcia S; Eritja R; Rodríguez-Alfaro JA; Gómez-Fernández JC; Fita I; Verdaguer N
    J Mol Biol; 2002 Jul; 320(2):277-91. PubMed ID: 12079385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory properties of the regulatory domains of human protein kinase Calpha and mouse protein kinase Cepsilon.
    Parissenti AM; Kirwan AF; Kim SA; Colantonio CM; Schimmer BP
    J Biol Chem; 1998 Apr; 273(15):8940-5. PubMed ID: 9535877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the calcium-binding sites of the C2 domain of protein kinase Calpha that are critical for its translocation to the plasma membrane.
    Corbalán-García S; Rodríguez-Alfaro JA; Gómez-Fernández JC
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):513-21. PubMed ID: 9895296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Calpha.
    Bornancin F; Parker PJ
    Curr Biol; 1996 Sep; 6(9):1114-23. PubMed ID: 8805373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase Calpha.
    Yeong SS; Zhu Y; Smith D; Verma C; Lim WG; Tan BJ; Li QT; Cheung NS; Cai M; Zhu YZ; Zhou SF; Tan SL; Duan W
    J Biol Chem; 2006 Oct; 281(41):30768-81. PubMed ID: 16895917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C2 domain of protein kinase calpha is directly involved in the diacylglycerol-dependent binding of the C1 domain to the membrane.
    Conesa-Zamora P; Gómez-Fernández JC; Corbalán-García S
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):246-54. PubMed ID: 11018476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid as a modulator of the activity of protein kinase Calpha.
    López-Andreo MJ; Torrecillas A; Conesa-Zamora P; Corbalán-García S; Gómez-Fernández JC
    Biochemistry; 2005 Aug; 44(34):11353-60. PubMed ID: 16114872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoinduced inactivation of protein kinase C by dequalinium identifies the RACK-1-binding domain as a recognition site.
    Rotenberg SA; Sun XG
    J Biol Chem; 1998 Jan; 273(4):2390-5. PubMed ID: 9442087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca(2+) bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphatidylserine.
    Verdaguer N; Corbalan-Garcia S; Ochoa WF; Fita I; Gómez-Fernández JC
    EMBO J; 1999 Nov; 18(22):6329-38. PubMed ID: 10562545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of the regulatory domain of rat protein kinase C-eta. A molecular basis for restricted histone kinase activity.
    Dekker LV; McIntyre P; Parker PJ
    J Biol Chem; 1993 Sep; 268(26):19498-504. PubMed ID: 8396139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion analysis of protein kinase C inactivation by calphostin C.
    Rotenberg SA; Huang MH; Zhu J; Su L; Riedel H
    Mol Carcinog; 1995 Jan; 12(1):42-9. PubMed ID: 7529505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ modulation of cis-unsaturated fatty acid-induced mutant protein kinase C activity: indication of inhibitory Ca2+-binding site in protein kinase C-alpha.
    Eshete F; Chung H; Gannon-Murakami L; Murakami K
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):215-21. PubMed ID: 9639582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid in vitro conformational changes of the catalytic site of PKC alpha assessed by FIM-1 fluorescence.
    Janoshazi A; de Barry J
    Biochemistry; 1999 Oct; 38(40):13316-27. PubMed ID: 10529207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium.
    Rotenberg SA; Smiley S; Ueffing M; Krauss RS; Chen LB; Weinstein IB
    Cancer Res; 1990 Feb; 50(3):677-85. PubMed ID: 2297708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.